On 12 October 2010 the FILA Sport Judge decided to impose a 12 month period of ineligibility on the Serbian Athlete Kristijan Fris after his sample tested positive for the prohibited substance furosemide.

Hereafter WADA appealed the FILA Sport Judge decision of 12 October 2010 with the FILA Appeal Commission.

The Appeal Commission rejects the Athlete's statement and concludes that the he acted negligently without research of the ingredients before using the medication. In addition the Commission notes that there is evidence that the Athlete wanted to keep his weight and might have used the substance to mask the use of an anabolic agent.
Therefore the FILA Appeal Commission decides to set aside the FILA Sport Judge decision of 12 October 2010 and to impose a 2 year period of ineligibility, starting on the date of the sample collection, i.e. 29 May 2010.

Facts
The French Federation of Volley-ball (French Volleyball Federation, FFVB) charges respondent M17 for a violation of the Anti-Doping Rules. The respondent hadn't provide his whereabouts data as being part of the registered testing pool.

History
Given the dates of February 19, 2009, of March 16, 2009 and May 10, 2010 the Agence Française de Lutte contre le Dopage (AFLD) sent the latter first, second and third warning.
Respondent explained he didn't react to the first and second because he lived alone without administrative support, the third time he was taking part in a training session of 5 months away from home.

Decision
1. The sanction is a period of ineligibility of six months in which respondent can't take part in competition or manifestation organized by the FFVB.
2. The period of ineligibility will be reduced by the period already served by the decision, dated October 27, 2010, of the disciplinary committee of the FFVB.
3. The decision (period of ineligibility of three months), dated October 27, 2010, of the disciplinary committee of the FFVB will be modified.
4. The decision starts on the date of notification.
5. The decision will be published and sent to the parties involved.

Therapeutic Use Exemptions : the World Anti-Doping Code International Standard / World Anti-Doping Agency (WADA). - Montreal : WADA, 2009. - (International Standard for Therapeutic Use Exemptions (ISTUE) version 4.0, effective on 1 January 2010)

The purpose of the International Standard for Therapeutic Use Exemptions is to ensure that the process of granting therapeutic use exemptions is harmonized across sports and countries.

The Code permits Athletes to apply for therapeutic use exemptions (TUE The International Standard for ) i.e. permission to use, for therapeutic purposes, substances or methods contained in the List of Prohibited Substances or Methods where Use would otherwise be prohibited.

TUE includes criteria for granting a TUE, confidentiality of information, the formation of Therapeutic Use Exemptions Committees and the TUE.

This Standard applies to all Athletes as defined by and subject to the Code i.e. able-bodied Athletes and Athletes with disabilities.

Facts
The French University Sport Federation (Fédération Française du Sport Universitaire, FFSU) charges respondent M16 for a violation of the Anti-Doping Rules. During a beach-volley tournament on June 10, 2010, a sample was taken for doping test purposes. The analysis of the sample showed the presence of a metabolite of cannabis. Cannabis is a prohibited substance according the World Anti-Doping Agency (WADA) and is regarded as a specified substance.

History
The respondent had used the prohibited substance in a social setting days before the doping test, there was no intention to enhance sport performances. This is a second violation, respondent had already received a sanction of a period of six months of ineligibility based on the decision, dated October 2, 2008, of the disciplinary committee of the FFSU.

Decision
1. The sanction is a period of ineligibility of two years, in which respondent can't take part in competition or manifestations organized by the FFSU, which is the same as the decision, dated October 7, 2010, of the disciplinary committee of the FFSU but extended to all French sport federation.
2. The decision will be published and sent to the parties involved.

THE 2014 MONITORING PROGRAM*

The following substances are placed on the 2014 Monitoring Program:

1. Stimulants:

In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (< 150 micrograms per milliliter), synephrine.

2. Narcotics: In-Competition only: Hydrocodone, mitragynine, morphine/codeine ratio; tapentadol; tramadol.

3. Glucocorticosteroids: Out-of-Competition only

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”

THE 2013 MONITORING PROGRAM*

The following substances are placed on the 2013 Monitoring Program:

1. Stimulants:

In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (<
150 micrograms per milliliter), synephrine.

2. Narcotics: In-Competition only: Hydrocodone, morphine/codeine ratio; tapentadol; tramadol.

3. Glucocorticosteroids: Out-of-Competition only

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”

THE 2012 MONITORING PROGRAM*

The following substances are placed on the 2012 Monitoring Program:

1. Stimulants:

In-Competition Only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (< 150 micrograms per milliliter), synephrine.

2. Narcotics: In-Competition Only: Hydrocodone, morphine/codeine ratio; tramadol.

3. Glucocorticosteroids: Out-of-Competition Only

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”

THE 2011 MONITORING PROGRAM*

The following substances are placed on the 2011 Monitoring Program:

1. Stimulants:

In-Competition Only: Bupropion, caffeine, phenylephrine, phenylpropanolamine, pipradrol, pseudoephedrine (< 150 micrograms
per milliliter), synephrine.

2. Narcotics:

In-Competition Only: Morphine/codeine ratio.

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect patterns of misuse in sport.”

2014 Prohibited List
Summary of Major Modifications and Explanatory Notes

PROHIBITED SUBSTANCES
Use of International Non-proprietary Names (INN)
With the assistance of the World Health Organisation, the nomenclature of some substances on the List has been updated to International Non-proprietary Names (INN). For ease of the reviewer the previous name has been included and no substance has been deleted.
S1. Anabolic Agents
• Changes were made to the definitions of “exogenous” and “endogenous” for purposes of clarification and accuracy.
S2. Peptide Hormones, Growth Factors and Related Substances
• Releasing factors are prohibited and that is made clear in points S2.2, S2.3 and S2.4. In addition other prohibited growth factors are listed separately.
S5. Diuretics and other Masking Agents
• Vasopressin V2 antagonists (vaptans) were added as an example of a diuretic subclass.
M1. Manipulation of Blood and Blood Components
• For the purpose of scientific accuracy, the term allogenic was introduced.
SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION
S6. Stimulants:
• Some drugs that metabolize to amfetamine or methamfetamine have been reclassified because improved analytical techniques permit the identification of the administered drug and corresponding metabolites; MDMA and MDA are reclassified because they are now recognized as less likely to be used as doping agents; cathinone and its analogues (e.g. mephedrone, methedrone, α- pyrrolidinovalerophenone) and trimetazidine have been added as examples to reflect emerging patterns of drug use.
SUBSTANCES PROHIBITED IN PARTICULAR SPORTS
P1. Alcohol
• Changes were made to the wording describing the blood alcohol threshold, in the interest of accuracy.
• “Aeronautic” has been replaced by “Air Sports” and “FITA” has been replaced by its new acronym “WA” (World Archery).
P2. Beta-blockers
• “FITA” has been replaced by its new acronym “WA” (World Archery)
MONITORING PROGRAM
• In order to detect potential patterns of abuse, mitragynine has been added to the Narcotics class of the Monitoring Program

On 14 October 2010 the FILA Sport Judge decided to give a reprimand to the Russian Athlete Anvar Gazimagomedov after his sample tested positive for the prohibited substance atenolol.
Hereafter WADA appealed the FILA Sport Judge decision of 14 October 2010 with the FILA Appeal Commission.

The Athlete claimed that there were several departures from the sample collection procedure and that the prohibited substance came into his body during his visit at the dentist or with the medication he used for his headache.

The Appeal Commission concludes that the Athlete produced no evidence in support of his allegations about the sample collection and his statement about how the prohibited substance came into his body.
Therefore the FILA Appeal Commission decides to set aside the FILA Sport Judge decision of 14 October 2010 and to impose a 2 year period of ineligibility on the Athlete, starting on the date of the sample collection, i.e. on 29 June 2010.